Sriya Life Science exports to 13 countries across five continents, including Africa, South-East Asia, North America, CIS, and Latin America. With a growing number of international product registrations, we are emerging as a leading Indian pharmaceutical manufacturer.

To streamline our export vision, we have established a dedicated Export Regulation department to manage international audits and provide complete export documentation, including COAs, COPPs, and COOs, as well as dossier preparations in the CTD format. Our manufacturing facility complies with cGMP standards and is certified by numerous regulatory agencies.

We aim to be the premier pharmaceutical manufacturer for India and neighboring countries by offering high-quality products at the right price and continually bringing the latest generics to market.







India, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan.

Kenya, Zimbabwe, Somalia, Djibouti.

Belarus, Macedonian.

Brazil, Venezuela

Policy on Partnering

Success through mutual understanding and trust. Meeting partner expectations. Satisfying partner needs.


Best price offerings. Accurate artwork and regulatory support. Assistance with promotional materials and marketing.

Labeling of Private Products

Customized service based on client specifications. Product development for diverse global needs. 

The Regulatory Services Division

Expert team. Guaranteeing product quality and safety. Compliance with clinical trials and FDA certificates.

Delivery & Dispatch

Utilizing climate-controlled storage facilities. Implementing continuous monitoring with advanced logistics solutions.

At SRIYA LIFE SCIENCE, the following factors have been essential to our success in manufacturing drugs for overseas markets:

  • Superior quality products.
  • Round-the-clock customer service.
  • Timely delivery.
  • Competitive pricing for quality products.
  • High compliance rate.
  • WHO-GMP certified facilities.
  • FDA-approved manufacturing.
  • Comprehensive regulatory support.